Clinical Trial Update: miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi

View source ↗

Summary

A completed clinical trial examining the role of miRNA machinery in cutaneous melanoma, metastatic melanoma, and benign melanocytic nevi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Melanocytic Nevi
• Cutaneous Melanoma
• Melanoma

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Cutaneous Melanoma, Nevi | Status: COMPLETED